Abstract
Acne vulgaris is a common skin condition in pregnant women. The choice of medication depends on the severity of the acne and the potential risks of the treatment. As a general rule, topical agents are safer than oral agents and should be the first choice, with oral agents and/or blue–violet or red light phototherapy considered as second-line treatments. The use of hormonal therapies, oral and topical retinoids and certain antibacterials should be avoided.
Similar content being viewed by others
References
Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs. 2013;73(8):779–87.
Meredith FM, Ormerod AD. The management of acne vulgaris in pregnancy. Am J Clin Dermatol. 2013;14(5):351–8.
US FDA pregnancy categories. http://depts.washington.edu/druginfo/Formulary/Pregnancy.pdf. Accessed 5 Aug 2013.
American Academy of Pediatric Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776.
US National Library of Medicine. Drugs and lactation database. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed 8 Aug 2013.
Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Phys. 2011;57(6):665–7.
Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol. 2002;41(4):197–203.
Galderma (UK) Ltd. Rozex cream (metronidazole Ph. Eur 0.75% w/w): summary of product characteristics. 2012. http://www.medicines.org.uk/emc/medicine/700/SPC/Rozex+Cream/. Accessed 6 Aug 2013.
Tuffanelli DL. Successful pregnancy in a patient with dermatitis herpetiformis treated with low-dose dapsone. Arch Dermatol. 1982;118(11):876.
Sanders SW, Zone JJ, Foltz RL, et al. Hemolytic anemia induced by dapsone transmitted through breast milk. Ann Intern Med. 1982;96(4):465–6.
Webster GF. Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients? J Drugs Dermatol. 2010;9(5):532–6.
Trivedi NA. A meta-analysis of low-dose aspirin for prevention of preeclampsia. J Postgrad Med. 2011;57(2):91–5.
Panchaud A, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52(12):1844–51.
Loureiro KD, Kao KK, Jones KL, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136(2):117–21.
Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167–97.
Feneran AN, Kaufman WS, Dabade TS, et al. Retinoid plus antimicrobial combination treatments for acne. Clin Cosmet Investig Dermatol. 2011;4:79–92.
Källén BA, Otterblad Olausson P, Danielsson BR BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol. 2005;20(2):209–14.
Mays RM, Gordon RA, Wilson JM, et al. New antibiotic therapies for acne and rosacea. Dermatol Ther. 2012;25(1):23–37.
Sorensen HT, Skriver MV, Pedersen L, et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104–6.
Ho JM, Juurlink DN. Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ. 2011;183(16):1851–8.
Briggs GG, Freeman RK, Yaffe SJ, editors. Drugs in pregnancy and lactation. 5th ed. Baltimore: Williams & Wilkins; 1998.
Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. Pediatr Surg. 1992;27(6):744–6.
Katsambas A, Dessinioti C. New and emerging treatments in dermatology: acne. Dermatol Ther. 2008;21(2):86–95.
Dréno B, Blouin E. Acne, pregnant women and zinc salts: a literature review. Ann Dermatol Venereol. 2008;135(1):27–33.
Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, et al. Periconceptional exposure to contraceptive pills and risk for Down syndrome. J Perinatol. 2001;21(5):288–92.
Disclosure
This article was adapted from Drugs 2013;73(8):779–87 [1]. The preparation of these articles was not supported by any external funding.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Consider acne severity and potential risks when treating acne vulgaris in pregnant and breastfeeding women. Drugs Ther Perspect 30, 16–20 (2014). https://doi.org/10.1007/s40267-013-0092-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-013-0092-2